# Anemia-Related Outcomes in Patients With CKD Treated With Dapagliflozin

> **NCT06813222** · — · ACTIVE_NOT_RECRUITING · sponsor: **Damanhour University** · enrollment: 100 (estimated)

## Conditions studied

- Anemia
- CKD

## Interventions

- **DRUG:** Dapagliflozin (DAPA)

## Key facts

- **NCT ID:** NCT06813222
- **Lead sponsor:** Damanhour University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-04-01
- **Primary completion:** 2025-03-01
- **Final completion:** 2025-03-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06813222

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06813222, "Anemia-Related Outcomes in Patients With CKD Treated With Dapagliflozin". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06813222. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*